{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:15Z","timestamp":1786979895574,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00261-021-03341-z","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T07:11:53Z","timestamp":1636528313000},"page":"586-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Use of MRI and Ga-68 DOTATATE for the detection of neuroendocrine liver metastases"],"prefix":"10.1007","volume":"47","author":[{"given":"Maera","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Goehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-7443","authenticated-orcid":false,"given":"Leo L.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"3341_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000481390","volume":"33","author":"G Kl\u00f6ppel","year":"2017","unstructured":"Kl\u00f6ppel G (2017) Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications. Visc Med 33:324\u2013330. https:\/\/doi.org\/https:\/\/doi.org\/10.1159\/000481390","journal-title":"Visc Med"},{"key":"3341_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/AJR.18.19881","volume":"211","author":"Y Sanli","year":"2018","unstructured":"Sanli Y, Garg I, Kandathil A, et al (2018) Neuroendocrine Tumor Diagnosis and Management: (68)Ga-DOTATATE PET\/CT. AJR Am J Roentgenol 211:267\u2013277. https:\/\/doi.org\/https:\/\/doi.org\/10.2214\/AJR.18.19881","journal-title":"AJR Am J Roentgenol"},{"key":"3341_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, et al (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197:29\u201337. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/S1072-7515(03)00230-8","journal-title":"J Am Coll Surg"},{"key":"3341_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/s1072-7515(00)00222-2","volume":"190","author":"RS Chamberlain","year":"2000","unstructured":"Chamberlain RS, Canes D, Brown KT, et al (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190:432\u2013445. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/s1072-7515(00)00222-2","journal-title":"J Am Coll Surg"},{"key":"3341_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12022-007-0020-x","volume":"18","author":"G Rindi","year":"2007","unstructured":"Rindi G, D\u2019Adda T, Froio E, et al (2007) Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol 18:145\u2013149. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s12022-007-0020-x","journal-title":"Endocr Pathol"},{"key":"3341_CR6","doi-asserted-by":"publisher","unstructured":"Musunuru S, Chen H, Rajpal S, et al (2006) Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg Chic Ill 1960 141:1000\u20131004; discussion 1005. https:\/\/doi.org\/10.1001\/archsurg.141.10.1000","DOI":"10.1001\/archsurg.141.10.1000"},{"key":"3341_CR7","unstructured":"National Comprehensive Cancer Network 2019? Guidelines for Neuroendocrine Tumors"},{"key":"3341_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1477-2574.2010.00175.x","volume":"12","author":"A Frilling","year":"2010","unstructured":"Frilling A, Sotiropoulos GC, Li J, et al (2010) Multimodal management of neuroendocrine liver metastases. HPB 12:361\u2013379. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00175.x","journal-title":"HPB"},{"key":"3341_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-9966-29-19","volume":"29","author":"M Appetecchia","year":"2010","unstructured":"Appetecchia M, Baldelli R (2010) Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives. J Exp Clin Cancer Res CR 29:19\u201319. https:\/\/doi.org\/https:\/\/doi.org\/10.1186\/1756-9966-29-19","journal-title":"J Exp Clin Cancer Res CR"},{"key":"3341_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G d\u2019Assignies","year":"2013","unstructured":"d\u2019Assignies G, Fina P, Bruno O, et al (2013) High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology 268:390\u2013399. https:\/\/doi.org\/https:\/\/doi.org\/10.1148\/radiol.13121628","journal-title":"Radiology"},{"key":"3341_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.2005.01.013","volume":"23","author":"C Dromain","year":"2005","unstructured":"Dromain C, de Baere T, Lumbroso J, et al (2005) Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol Off J Am Soc Clin Oncol 23:70\u201378. https:\/\/doi.org\/https:\/\/doi.org\/10.1200\/JCO.2005.01.013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3341_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.crad.2016.05.016","volume":"71","author":"LP Lavelle","year":"2016","unstructured":"Lavelle LP, O\u2019Neill AC, McMahon CJ, et al (2016) Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases? Clin Radiol 71:863\u2013868. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.crad.2016.05.016","journal-title":"Clin Radiol"},{"key":"3341_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2967\/jnumed.112.111724","volume":"54","author":"D Wild","year":"2013","unstructured":"Wild D, Bomanji JB, Benkert P, et al (2013) Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors. J Nucl Med Off Publ Soc Nucl Med 54:364\u2013372. https:\/\/doi.org\/https:\/\/doi.org\/10.2967\/jnumed.112.111724","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"3341_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","volume":"39","author":"L Kabasakal","year":"2012","unstructured":"Kabasakal L, Demirci E, Ocak M, et al (2012) Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 39:1271\u20131277. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s00259-012-2123-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3341_CR15","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","volume":"52","author":"TD Poeppel","year":"2011","unstructured":"Poeppel TD, Binse I, Petersenn S, et al (2011) 68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors. J Nucl Med Off Publ Soc Nucl Med 52:1864\u20131870. https:\/\/doi.org\/https:\/\/doi.org\/10.2967\/jnumed.111.091165","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"3341_CR16","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s00261-021-02990-4","volume":"46","author":"T Jackson","year":"2021","unstructured":"Jackson T, Darwish M, Cho E, et al (2021) 68Ga-DOTATATE PET\/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Abdom Radiol N Y 46:3179\u20133183. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s00261-021-02990-4","journal-title":"Abdom Radiol N Y"},{"key":"3341_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1309\/UKN6-PVRK-XHG4-22DA","volume":"123","author":"A Saqi","year":"2005","unstructured":"Saqi A, Alexis D, Remotti F, Bhagat G (2005) Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol 123:394\u2013404. https:\/\/doi.org\/https:\/\/doi.org\/10.1309\/UKN6-PVRK-XHG4-22DA","journal-title":"Am J Clin Pathol"},{"key":"3341_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2016.01.002","volume":"30","author":"IM Modlin","year":"2016","unstructured":"Modlin IM, Bodei L, Kidd M (2016) Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Best Pract Res Clin Endocrinol Metab 30:59\u201377. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.beem.2016.01.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3341_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/RLU.0000000000001753","volume":"42","author":"D Berzaczy","year":"2017","unstructured":"Berzaczy D, Giraudo C, Haug AR, et al (2017) Whole-Body 68Ga-DOTANOC PET\/MRI Versus 68Ga-DOTANOC PET\/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients. Clin Nucl Med 42:669\u2013674. https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/RLU.0000000000001753","journal-title":"Clin Nucl Med"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-021-03341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-021-03341-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-021-03341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T02:03:22Z","timestamp":1643681002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-021-03341-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3341"],"URL":"https:\/\/doi.org\/10.1007\/s00261-021-03341-z","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"28 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Leo Tsai is a consultant for Agile Devices, a medical device company with no connection to this study. No other author disclosures are noted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}